Skip to main content
EZZ LIFE SCIENCE HOLDINGS LIMITED logo

EZZ LIFE SCIENCE HOLDINGS LIMITED — Investor Relations & Filings

Ticker · EZZ ISIN · AU0000130569 ASX Manufacturing
Open in API
Filings indexed 150 across all filing types
Latest filing 2026-04-29 Interim / Quarterly Rep…
Country AU Australia
Listing ASX EZZ

About EZZ LIFE SCIENCE HOLDINGS LIMITED

https://ezzlife.com.au

EZZ Life Science Holdings Limited is a life sciences company focused on genomic research and development to address human health challenges. The company specializes in the formulation, production, and marketing of health supplements, skincare products, and wellness solutions. Its core research areas include longevity, weight management, and human papillomavirus (HPV) prevention. EZZ operates through its own brand, EZZ, while also acting as a wholesale distributor for the EAORON skincare range. The company leverages data-driven insights to develop products targeting the aging process and metabolic health. Its distribution network spans across various international markets, with a strong emphasis on digital retail platforms and e-commerce channels to reach a global consumer base.

Recent filings

Filing Released Lang Actions
Quarterly Activity and Cashflow Report 9 pages 490.7KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 30 April 2026 presenting the Appendix 4C and Quarterly Activity Report for the quarter ended 31 March 2026. It includes detailed financial data such as cash flows from operating, investing, and financing activities, cash balances, and a reconciliation of cash and cash equivalents. It also contains narrative on business activities, strategic partnerships, product innovation, governance updates, and outlook commentary. The presence of the Appendix 4C (a quarterly cash flow report required by ASX Listing Rule 4.7B) and substantive financial data for a quarter indicates this is a comprehensive interim/quarterly report rather than a brief announcement or a simple regulatory filing. The document length (15,000 characters) and detailed financial tables further support classification as an Interim / Quarterly Report (IR). Q3 2026
2026-04-29 English
Half Yearly Report and Accounts 25 pages 1.2MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'EZZ Life Science Holdings Limited Appendix 4D Half-year report' and covers the half-year ended 31 December 2025. It includes detailed financial performance data, financial position, net tangible assets, dividends, and a comprehensive Directors' report with operational review, market conditions, cash position, product innovation, and outlook. The document contains actual financial statements and substantive financial data for a period shorter than a full fiscal year, consistent with an interim or quarterly report. The presence of an auditor's review report and detailed financial statements further supports this classification. The document is approximately 15,000 characters long, indicating it is the full report, not just an announcement or summary. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2026
2026-02-26 English
Quarterly Activities/Appendix 4C Cashflow Report 9 pages 469.0KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement dated 30 January 2026 presenting the Appendix 4C and Quarterly Activity Report for the quarter ended 31 December 2025 (Q2 FY26). It includes detailed financial data such as cash flow statements, operating cash outflows, investing and financing activities, and commentary on business activities and outlook. The presence of the Appendix 4C, which is a quarterly cash flow report required by ASX Listing Rule 4.7B, and the detailed quarterly operational and financial commentary indicate this is a comprehensive interim/quarterly report. The document is about 15,000 characters long, which is substantial and contains actual financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q2 2026
2026-01-29 English
Appointment of Non-Executive Chair 1 page 210.4KB
Board/Management Information Classification · 100% confidence The document is an announcement from EZZ Life Science Holdings Limited regarding the appointment of a new Non-Executive Chair of the Board. It focuses on changes in the company's board leadership and governance structure. There are no financial statements, earnings data, or detailed reports included. The content fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2026-01-21 English
Initial Director's Interest Notice x 3 6 pages 337.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the initial interests of newly appointed directors in securities, including the number and class of securities held or relevant interests, as well as any interests in contracts. The content is focused on disclosures of directors' personal shareholdings and interests, which aligns with insider trading and director dealings reporting requirements. There is no financial performance data, earnings information, or management discussion. The document is not an announcement of a report but a direct disclosure of directors' share transactions and interests. Therefore, it fits the category of Director's Dealing (DIRS). The document length and detail support a high confidence classification.
2026-01-21 English
Appointment of Directors 1 page 210.9KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 16 January 2026 regarding the appointment of two directors to the company's Board. It details the names, roles, and backgrounds of the new directors and includes a comment from the CEO and Interim Chair. There is no financial data, no mention of a report or financial results, and the content focuses solely on changes in the company's board of directors. This fits the definition of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication but a direct announcement of management changes.
2026-01-15 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.